Inspire(US:INSP) Globenewswireยท2025-11-11 13:27Core Viewpoint - A class action lawsuit has been filed against Inspire Medical Systems, Inc. for alleged violations of federal securities laws during the Class Period from August 6, 2024, to August 4, 2025, seeking to recover losses for investors [1][3]. Company Overview - Inspire Medical develops and manufactures an implantable medical device for obstructive sleep apnea known as Inspire, with the latest version, Inspire V, designed to improve respiration during sleep [4]. Lawsuit Details - The lawsuit, titled City of Pontiac Reestablished General Employees' Retirement System v. Inspire Medical Systems, Inc., alleges that the company and certain senior executives made false and misleading statements and failed to disclose critical issues regarding the Inspire V rollout [3][4]. - On August 4, 2025, Inspire Medical disclosed that the rollout of Inspire V faced an "elongated timeframe" due to undisclosed issues, including delays in software updates for billing Medicare patients, which only took effect on July 1, 2025 [4]. - The company acknowledged that demand for Inspire V was negatively impacted by excess channel inventory, leading to a reduction in its 2025 earnings guidance by more than 80% [4]. Stock Performance Impact - Following the negative disclosures, Inspire Medical's stock price declined by more than 32%, resulting in significant losses for investors [4].